FREQUENCY OF DYSLIPIDEMIA AMONG STROKE PATIENTS PRESENTING AT TERTIARY CARE HOSPITAL
DOI:
https://doi.org/10.71000/aea7pd71Keywords:
Cerebrovascular Disorders, Cholesterol, Cross-Sectional Studies, Dyslipidemias, Hemorrhagic Stroke, Ischemic Stroke, Lipid ProfileAbstract
Background: Stroke remains one of the leading causes of mortality and long-term disability worldwide. Dyslipidemia is a recognized modifiable risk factor contributing to atherosclerosis and ischemic events. However, its frequency and distribution among different stroke subtypes remain variably reported in different populations.
Objective: To determine the frequency of dyslipidemia among patients presenting with stroke to a tertiary care hospital and assess its distribution across ischemic and hemorrhagic stroke subtypes.
Methods: A cross-sectional study was conducted at the Department of Medicine, Saidu Group of Teaching Hospital, Swat, over a period of six months. A total of 171 patients aged 20–75 years with CT-confirmed ischemic or hemorrhagic stroke were enrolled using non-probability consecutive sampling. Data on demographics, clinical history, and comorbidities were collected. Fasting lipid profiles were analyzed, and dyslipidemia was diagnosed based on standard criteria. Statistical analysis was conducted using SPSS v.21, with stratification and chi-square testing applied to assess associations.
Results: Among 171 stroke patients, 128 (74.9%) had ischemic stroke and 43 (25.1%) had hemorrhagic stroke. Dyslipidemia was present in 96 patients (56.1%), with higher prevalence in ischemic stroke (64.1%) compared to hemorrhagic stroke (32.6%). Gender distribution of dyslipidemia was comparable between males (57.7%) and females (54.1%). Common comorbidities included hypertension (57.9%) and diabetes mellitus (37.4%).
Conclusion: Dyslipidemia was frequently observed among stroke patients, particularly those with ischemic stroke. These findings support the inclusion of routine lipid screening in stroke evaluations and highlight the need for early interventions to reduce stroke burden through targeted lipid control strategies.
References
Qureshi AI, Baskett WI, Huang W, Shyu D, Myers D, Raju M, et al. Acute Ischemic Stroke and COVID-19: An Analysis of 27 676 Patients. Stroke. 2021;52(3):905-12.
Lee DH, Sheen SH, Lee DG, Jang JW, Lee DC, Shin SH, et al. Association between ischemic stroke and seropositive rheumatoid arthritis in Korea: A nationwide longitudinal cohort study. PLoS One. 2021;16(5):e0251851.
Hoshino T, Ishizuka K, Toi S, Mizuno T, Nishimura A, Takahashi S, et al. Atherogenic Dyslipidemia and Residual Vascular Risk After Stroke or Transient Ischemic Attack. Stroke. 2022;53(1):79-86.
Ohya Y, Matsuo R, Sato N, Irie F, Nakamura K, Wakisaka Y, et al. Causes of ischemic stroke in young adults versus non-young adults: A multicenter hospital-based observational study. PLoS One. 2022;17(7):e0268481.
Pudasaini A, Sherpa P, Khadka T, Giri G, Parajuli S, Shrestha S, et al. Dyslipidemia among Patients with Ischemic Stroke Admitted to the Department of Medicine of a Tertiary Care Centre. JNMA: Journal of the Nepal Medical Association. 2023;61:718-22.
Baral S, Kshetri R, Gyawali P, Regmi P, Pokhrel A, B.K SK. Dyslipidemia among Patients with Ischemic Stroke in the Department of Medicine of a Tertiary Care Centre: A Descriptive Cross-sectional Study. JNMA: Journal of the Nepal Medical Association. 2022;60:511-6.
Karn R, Gajurel B, Ojha R, Rajbhandari R, Gurung A. Dyslipidemia and Obesity in Ischemic Stroke. Cureus. 2023;15.
Yadav A, Sawant V, Singh Bedi V, Yadav K. Dyslipidemia and peripheral arterial disease. Indian Heart J. 2024;76 Suppl 1(Suppl 1):S86-s9.
Løvik K, Laupsa-Borge J, Logallo N, Helland CA. Dyslipidemia and rupture risk of intracranial aneurysms-a systematic review. Neurosurg Rev. 2021;44(6):3143-50.
Sah N, Panthi S, Shah S, Basnet LB, Pandey SR, Shrestha A, et al. Dyslipidemia in Acute Non-cardioembolic Ischemic Stroke Patients at a Tertiary Care Centre: A Descriptive Cross-sectional Study. JNMA: Journal of the Nepal Medical Association. 2022;60:241-5.
Wadström BN, Pedersen KM, Wulff AB, Nordestgaard BG. Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study. Diabetologia. 2023;66(12):2238-49.
Ho WM, Wu YY, Chen YC. Genetic Variants behind Cardiovascular Diseases and Dementia. Genes (Basel). 2020;11(12).
Tuz AA, Hoerenbaum N, Ulusoy Ö, Ahmadi A, Gerlach A, Beer A, et al. Hypercholesterolemia triggers innate immune imbalance and transforms brain infarcts after ischemic stroke. Front Immunol. 2024;15:1502346.
Nussbaumerová B. [Hypertension and dyslipidemia treament in stroke]. Vnitr Lek. 2022;68(3):172-7.
Smith C, Wallis S, Katsas G, Dincarslan O, Dawson J, Cameron A. Impact of European Stroke Organisation secondary prevention guideline for ischaemic stroke / transient ischaemic attack. J Stroke Cerebrovasc Dis. 2024;33(12):108034.
Unda SR, Antoniazzi AM, Miller R, Klyde D, Javed K, Fluss R, et al. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors. J Stroke Cerebrovasc Dis. 2021;30(9):105965.
Jung J-M, Seo W. Practical Dyslipidemia Management in Stroke-Specific Situations. Stroke Revisited: Dyslipidemia in Stroke. 2021.
Nwafor C, Onep-Onne N, Ogbak. Prevalence and pattern of dyslipidemia among patients with ischemic stroke in a tertiary care center in south- south Nigeria. World Journal of Biology Pharmacy and Health Sciences. 2024.
Nawaz M, Rehman Z, Anwar MS, Nadeem HM, Khan RSU, Khan S, et al. Prevalence of Dyslipidemia in Ischemic Stroke Patients: A Single-Center Prospective Study From Pakistan. Cureus. 2022;14.
Azeez TA, Yaria J, Adetunji TA. Stroke and dyslipidaemia in Africa: a meta-analysis of case-control studies. J Thromb Thrombolysis. 2023;56(1):188-95.
Diener HC, Hankey GJ. Primary and secondary prevention of ischemic stroke and cerebral hemorrhage: JACC focus seminar. J Am Coll Cardiol. 2020;75(15):1804-18.
Ye F, Garton HJ, Hua Y, Keep RF, Xi G. The role of thrombin in brain injury after hemorrhagic and ischemic stroke. Stroke Research. 2021;12(17):496-511.
Virani SS, Smith Jr SC, Stone NJ, Grundy SM. Secondary prevention for atherosclerotic cardiovascular disease: comparing recent US and European guidelines on dyslipidemia. Circulation. 2020;141(14):1121-3.
Gul MM, Ali W, Iqbal S, Bano M, Memon A, Hussain W. Frequency of dyslipidemia in patients presented with ischemic stroke. Pak J Med Health Sci. 2021;35(34):1212-4.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Karim Ullah, Muhammad Ayub Khan (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
